Suryadevara, V. et al. 2023. Comparing Safety and Efficacy of Rituximab and Eculizumab in Treating Refractory Myasthenia Gravis: A Systematic Review. Journal For International Medical Graduates. 2, 2 (Sep. 2023). DOI:https://doi.org/10.56570/jimgs.v2i2.138.